Your browser doesn't support javascript.
loading
MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma.
Zhu, Jinrong; Wu, Yongqi; Yu, Yijian; Li, Yan; Shen, Jianfei; Zhang, Rongxin.
Afiliación
  • Zhu J; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
  • Wu Y; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
  • Yu Y; Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, China.
  • Li Y; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
  • Shen J; Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, China. jianfei051@163.com.
  • Zhang R; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China. rxzhang@gdpu.edu.cn.
Cell Death Dis ; 13(8): 727, 2022 08 20.
Article en En | MEDLINE | ID: mdl-35987690

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transactivadores / Proteínas Proto-Oncogénicas / Carcinoma Hepatocelular / Resistencia a Antineoplásicos / Angiopoyetina 2 / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Death Dis Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transactivadores / Proteínas Proto-Oncogénicas / Carcinoma Hepatocelular / Resistencia a Antineoplásicos / Angiopoyetina 2 / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Death Dis Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido